Answers are grounded in this paper and cite their sources.
In this month's editorial, PLOS Medicine Editorial Board member Anushka Patel and Ruth Webster discuss how applying rules for drug efficacy trials can impede pragmatic trials of interventions for noncommunicable diseases.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: